5α-reductase inhibitors and type II diabetes

An international study has recently investigated the incidence of new onset type 2 diabetes mellitus amongst men treated with dutasteride, finasteride or tamsulosin for long term treatment of benign prostatic hyperplasia. The subjects received dutasteride (n=8231),...

A review of drug-induced movement disorders

Medications can be implicated as a cause of movement disorders, examples of clinically important syndromes include tremor, akathisia, parkinsonism and dyskinesia. An excellent review has recently been published in the Australian Prescriber, and can be viewed...

More involvement of pharmacists, shorter hospital stays

Can input from clinical pharmacist interventions impact upon length of hospital stay (LOS)? Recently published research suggests so. A high-quality study evaluated the impact of pharmacist-driven interventions on LOS across three practice areas (medicine,...